Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa

International audienceIntroduction: Low BMD is frequent in anorexia nervosa (AN), depression, and during SSRI treatment but relation between these elements in AN is not established. The aims of this study were to assess the relationships between depression and anxiety, SSRI prescription, and (1) low BMD during inpatient treatment and (2) BMD change 1 year after hospital discharge. Methods: From 2009 to 2011, 212 women with severe AN have been included in the EVHAN study (EValuation of Hospitalisation for AN). Depression, anxiety and obsessive–compulsive symptoms and comorbidity were evaluated using psychometric scales and CIDI-SF. BMD was measured by dual-energy X-ray absorptiometry. Results: According to the CIDI-SF, 56% of participants (n = 70) had a lifetime major depressive disorder, 27.2% (n = 34) had a lifetime obsessive–compulsive disorder, 32.8% (n = 41) had a lifetime generalized anxiety disorder and 25.6% (n = 32) had a lifetime social phobia disorder. Half of the sample (50.7%; n = 72) had a low BMD (Z score ≤ − 2). In multivariate analysis, lifetime lowest BMI was the only determinant significantly associated with low BMD (OR = 0.56, p = 0.0008) during hospitalization. A long duration of AN (OR = 1.40 (0.003–3.92), p = 0.03), the AN-R subtype (OR = 4.95 (1.11–26.82), p = 0.04), an increase of BMI between the admission and 1 year (OR = 1.69 (1.21–2.60), p = 0.005) and a gain of BMD 1 year after the discharge explained BMD change. Conclusion: We did not find any association between depression and anxiety or SSRI treatment and a low BMD or variation of BMD. Level of evidence: Level III, cohort study